Share on StockTwits
 

Research Analysts’ price target changes for Wednesday, February 26th:

Anika Therapeutics (NASDAQ:ANIK) had its target price boosted by Summer Street from $47.00 to $60.00. Summer Street currently has a buy rating on the stock.

TD Banknorth (NYSE:BNK) had its target price boosted by Wood & Company from $4.06 to $6.06.

DreamWorks Animation SKG (NYSE:DWA) had its price target lowered by B. Riley from $33.50 to $32.00. B. Riley currently has a neutral rating on the stock.

EOG Resources (NYSE:EOG) had its target price boosted by Howard Weil from $191.00 to $210.00. The firm currently has a sector outperform rating on the stock.

Envision Healthcare Holdings (NASDAQ:EVHC) had its target price increased by Oppenheimer from $39.00 to $41.00. Oppenheimer currently has an outperform rating on the stock.

Exterran Holdings (NYSE:EXH) had its target price increased by Howard Weil from $42.00 to $44.00. They currently have a sector outperform rating on the stock.

First Solar (NASDAQ:FSLR) had its target price trimmed by Goldman Sachs to $42.00. They currently have a sell rating on the stock.

Globe Specialty Metals (NYSE:GSM) had its price target boosted by Oppenheimer from $19.00 to $23.00. Oppenheimer currently has an outperform rating on the stock.

InterMune (NASDAQ:ITMN) had its target price raised by Canaccord Genuity from $22.00 to $46.00. The firm currently has a buy rating on the stock.

Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) had its price target raised by Citigroup Inc. from $132.00 to $195.00. They currently have a buy rating on the stock.

Gladstone Land Corp (NASDAQ:LAND) had its target price trimmed by JMP Securities from $19.00 to $15.50.

Gladstone Land Corp (NASDAQ:LAND) had its price target cut by Maxim Group from $19.00 to $17.00. Maxim Group currently has a buy rating on the stock.

Questcor Pharmaceuticals (NASDAQ:QCOR) had its price target raised by Oppenheimer from $90.00 to $99.00. Oppenheimer currently has an outperform rating on the stock.

QEP Resources (NYSE:QEP) had its price target lowered by Howard Weil from $43.00 to $40.00. Howard Weil currently has a sector outperform rating on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.